Mutated ATP10B Increases Parkinson’s Disease Risk by Compromising Lysosomal Glucosylceramide Export

Acta Neuropathologica - Germany
doi 10.1007/s00401-020-02145-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Autophagic- And Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows

Cells
2019English

LRRK2 Kinase Activity Regulates Lysosomal Glucocerebrosidase in Neurons Derived From Parkinson’s Disease Patients

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Premorbid Personality and the Risk of Parkinson’s Disease

Journal of Neurology Research
2014English

Gout and the Risk of Parkinson’s Disease in Denmark

European Journal of Epidemiology
Epidemiology
2013English

Metabolic Syndrome: An Important Risk Factor for Parkinson’s Disease

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2014English

Dopaminergic Influences on Risk Preferences of Parkinson’s Disease Patients

Cognitive, Affective and Behavioral Neuroscience
Behavioral NeuroscienceCognitive Neuroscience
2018English

Lack of Specificity of Antibodies Raised Against CLN3, the Lysosomal/Endosomal Transmembrane Protein Mutated in Juvenile Batten Disease

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2017English

Midnolin Is a Confirmed Genetic Risk Factor for Parkinson’s Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2019English

More Evidence That Gum Disease Increases Cancer Risk

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy